Year: 2000
Type: article
Abstract: Neuronal death in the retina has been studied not only because of its own biological importance and its relevance to clinical disease, but also because retinal apoptosis serves as a model system for death elsewhere in the central nervous system (Nickells and Zack 1996). Neurodegenerative retinal diseases in which apoptosis has been implicated include photoreceptor degenerations such as retinitis pigmentosa and age-related degeneration, retinal ganglion cell diseases such as glaucoma and other optic neuropathies, and more panretinal diseases like diabetic retinopathy. In an effort to develop novel treatment approaches for these diseases, various anti-apoptotic strategies have been explored. Transgenically engineered overexpression of bcl-2 in retinal ganglion cells leads to an inhibition of developmental apoptosis and relative resistance of ganglion cells to toxic insults such as optic nerve axotomy. Although more controversial, some results suggest that bcl-2 overexpression can also protect photoreceptors from damage (Chen et al. 1996). Perhaps more promising from a clinical point of view, neurotrophic factors, which inhibit neuronal apoptosis in a wide variety of systems, inhibit ganglion and photoreceptor cell death both in vitro and in vivo (Steinberg 1994; LaVail et al. 1998).
Source: Neuron
Author: Donald J. Zack
Institutions: Johns Hopkins University, Johns Hopkins Medicine
Language: English
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $10,400
OpenAlex ID: W2021450706
